Christina (Tina) P/LinkedIn
Aug 9, 2026, 08:46
Christina Pohlman: Uncovering the Autoantibodies Behind APS
Christina Pohlman, CEO and Co-Founder of APS Foundation of America, shared a post on LinkedIn:
“Study Alert:
In brief, we’re conducting this study to investigate the pathogenic autoantibodies that drive Antiphospholipid Syndrome.”
Other posts featuring Christina Pohlman on Hemostasis Today.
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation
-
Aug 9, 2026, 10:01Irma Bagdoniene: Plaque Stability and the Importance of LDL Lowering
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
-
Aug 9, 2026, 08:29Heba Youssef: Off-Label Doesn’t Mean Off-Guidelines
-
Aug 9, 2026, 08:18Fawaz AlOtaibi: Why Experts Are Challenging the New Stroke Guideline